Jane E. Henney
This article includes a improve this article by introducing more precise citations. (November 2011) ) |
Jane Henney | |
---|---|
18th Commissioner of Food and Drugs | |
In office January 17, 1999 – January 19, 2001 | |
President | Bill Clinton |
Preceded by | David A. Kessler |
Succeeded by | Mark McClellan |
Personal details | |
Born | 1947 (age 76–77) University of Texas MD Anderson Cancer Center |
Jane Ellen Henney (born 1947) is an American physician who was the first woman to serve as commissioner of the U.S. Food and Drug Administration. Appointed by President Bill Clinton, she served at the FDA from 1999 to 2001.[1]
Education and career
Jane Henney was born in
Prior to her appointment as commissioner, Henney had worked at the FDA from 1992 to 1994 as deputy commissioner for operations under then-commissioner
A significant and far reaching decision by the FDA under her tenure, was the ban on supplements and natural products that contain lovastatin, effectively handing exclusivity of cholesterol lowering compounds to pharmaceutical companies. AstraZeneca benefited directly from this decision this removed a cheap, natural product, from competing with their own statin rosuvastatin.
She was named senior vice president and provost for health affairs at the University of Cincinnati in 2003. In 2012, she was appointed to the Board of Directors of Cubist Pharmaceuticals.[3]
References
- ^ Office of the Commissioner (2022-02-28). "Jane Henney | FDA". www.fda.gov. Retrieved 2024-03-18.
- ^ National Library of Medicine (14 October 2003). "Changing the Face of Medicine".
- ^ "Cubist Pharmaceuticals Appoints Jane Henney to Board of Directors". www.businesswire.com. 2012-03-09. Retrieved 2024-03-18.
- Charles Marwick, "Jane E. Henney, MD, Is New FDA Commissioner", JAMA. 1998;280:1731-1732.
External links
- National library of Medicine about Jane Ellen Henney
- Jane E. Henney at the F.D.A. website
- Appearances on C-SPAN